NECTAR LIFESCIENCES
Back to Income Statement
|
NECTAR LIFESCIENCES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | - | ₹1,684 Cr | ₹1,524 Cr | ₹1,669 Cr | ₹1,543 Cr |
What is the latest Revenue of NECTAR LIFESCIENCES ?
| Year | Revenue |
|---|---|
| Mar2026 | - |
| Mar2025 | ₹1,684 Cr |
| Mar2024 | ₹1,524 Cr |
| Mar2023 | ₹1,669 Cr |
| Mar2022 | ₹1,543 Cr |
How is Revenue of NECTAR LIFESCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | - | -100.00 | |
| Mar2025 | ₹1,684 Cr | 10.53 | |
| Mar2024 | ₹1,524 Cr | -8.70 | |
| Mar2023 | ₹1,669 Cr | 8.13 | |
| Mar2022 | ₹1,543 Cr | - | |
Compare Revenue of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹195.3 Cr | -0.8% | -11.7% | -28.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,427.0 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,982.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,196.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,746.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,894.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -0.8% |
-11.7% |
-28.1% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses